Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG‐PET
- 1 June 2009
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 24 (10) , 1504-1511
Abstract
In Parkinson's disease patients with cognitive deterioration, regional cortical hypometabolism has been observed with [18F]fluorodeoxyglucose‐positron emission tomography (FDG‐PET). Our aim was to develop a robust method to subsume the overall degree of metabolic deterioration in Parkinson's disease by means of a single index and to investigate which of the clinical features correlates best with hypometabolism. Twenty‐two Parkinson's patients (10 demented) and seven controls underwent FDG‐PET. A metabolic index (mean relative uptake in typically affected regions) was calculated for each patient and compared with scores for cognition [Minimental State Examination (MMSE)], motor performance [Unified Parkinson's Disease Rating Scale (UPDRS III)” and behavior (Neuropsychiatric Inventory). In stepwise linear regression analysis, MMSE (P < 0.001) score showed the only significant effect. Estimated sensitivity and specificity for DSM‐IV diagnosis of dementia were high for the metabolic index (MI), with 91 and 100%. Taken together, the presented data indicate that cerebral hypometabolism in Parkinson's disease is primarily associated with cognitive impairment. © 2009 Movement Disorder SocietyKeywords
Funding Information
- AKF program
- University of Tuebingen
This publication has 38 references indexed in Scilit:
- Changes in Cerebral Glucose Metabolism in Patients with Parkinson Disease with Dementia After Cholinesterase Inhibitor TherapyJournal of Nuclear Medicine, 2008
- Cognitive dysfunction and dementia in Parkinson diseaseMovement Disorders, 2007
- Neuropathology of dementia in Parkinson's disease: A prospective, community‐based studyAnnals of Neurology, 2005
- Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's diseaseMovement Disorders, 2002
- Risk factors for dementia, depression and psychosis in long-standing Parkinson's diseaseJournal of Neural Transmission, 2000
- Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?Brain, 1995
- The Neuropsychiatric InventoryNeurology, 1994
- Criteria for the Diagnosis of Alzheimer's Disease with Positron Emission TomographyDementia and Geriatric Cognitive Disorders, 1990
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- “Mini-mental state”Journal of Psychiatric Research, 1975